Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 200-Day Moving Average

Technical Analysis - ARQT recently surpassed the 200-day moving average, indicating a long-term bullish trend [1] - The 200-day moving average is a widely-used indicator for establishing long-term market trends [2] - ARQT shares have increased by 21% over the past four weeks [2] Earnings and Revisions - ARQT has seen positive earnings estimate revisions, with no lower estimates in the past two months [3] - Three higher estimates have been made for the current fiscal year, and the consensus estimate has also increased [3] Investment Potential - ARQT is currently rated as a Zacks Rank 2 (Buy) stock, suggesting potential for continued growth [2] - The combination of positive earnings revisions and technical indicators supports a bullish outlook for ARQT [3]